Science Explorer Back to mapMap
Discussion
Company · San Francisco · United States

Rigel (United States)

rigel.comROR OpenAlex
World rank, all time
#34,552
of 34,923
Rank in United States
#7,248
of 7,310
Research works
129
▲ 5% vs 2018-21
Citations
4.2k
32.9 per fractional work
Top-10% rate
10.5%
all institutions 10.0%
vs its own fields
1.01×
1.00× is exactly expected
Open access
37%
world 40%
International
21%
world 18%
Rigel (United States)

Which fields of science does Rigel (United States) work in?

In all years, 48% of research at Rigel (United States) is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (13%). It does 2.4× the world's share of Life Sciences.

Health Sciences: 61 fractional works · 47.7% of its workMedicine: 59 fractional works · 45.6% of its workHematology: 9 fractional works · 7.2% of its workOncology: 8 fractional works · 6.3% of its workGenetics: 8 fractional works · 6.0% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 3.1% of its workPhysiology: 4 fractional works · 3.1% of its workSurgery: 4 fractional works · 3.0% of its workPathology and Forensic Medicine: 3 fractional works · 2.4% of its workPulmonary and Respiratory Medicine: 3 fractional works · 2.3% of its workPharmacology: 2 fractional works · 1.8% of its workEpidemiology: 2 fractional works · 1.5% of its workRheumatology: 2 fractional works · 1.5% of its workHepatology: 1 fractional works · 1.0% of its workImmunology and Allergy: 1 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.5% of its workInfectious Diseases: 1 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.4% of its workDermatology: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workTransplantation: 0 fractional works · 0.3% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workOtorhinolaryngology: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.8% of its workHealth Professions: 3 fractional works · 2.1% of its workMedical Laboratory Technology: 2 fractional works · 1.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workLife Sciences: 51 fractional works · 40.0% of its workBiochemistry, Genetics and Molecular Biology: 30 fractional works · 23.4% of its workMolecular Biology: 23 fractional works · 18.2% of its workCell Biology: 3 fractional works · 2.2% of its workCancer Research: 2 fractional works · 1.7% of its workGenetics: 1 fractional works · 0.9% of its workBiophysics: 0 fractional works · 0.4% of its workImmunology and Microbiology: 17 fractional works · 13.3% of its workImmunology: 17 fractional works · 13.1% of its workVirology: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 2.3% of its workPharmaceutical Science: 1 fractional works · 1.1% of its workPharmacology: 1 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 1 fractional works · 0.9% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.0% of its workPhysical Sciences: 15 fractional works · 11.6% of its workChemistry: 10 fractional works · 7.6% of its workOrganic Chemistry: 8 fractional works · 6.5% of its workSpectroscopy: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 3 fractional works · 2.2% of its workInformation Systems: 1 fractional works · 0.8% of its workArtificial Intelligence: 1 fractional works · 0.7% of its workSignal Processing: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 1 fractional works · 1.1% of its workBiomedical Engineering: 1 fractional works · 0.5% of its workElectrical and Electronic Engineering: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 1 fractional works · 0.5% of its workBiomaterials: 1 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 0.7% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.1% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKRigel (UnitedStates)129fractional works, all years
Life Sciences40%Physical Sciences12%Health Sciences48%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine5945.6%
    2. Health Professions32.1%
    1. Biochemistry, Genetics and Molecular Biology3023.4%
    2. Immunology and Microbiology1713.3%
    3. Pharmacology, Toxicology and Pharmaceutics32.3%
    4. Agricultural and Biological Sciences10.9%
    5. Neuroscience00.0%
    1. Chemistry107.6%
    2. Computer Science32.2%
    3. Engineering11.1%
    4. Materials Science10.5%
    5. Environmental Science00.1%
    6. Mathematics00.1%
    7. Physics and Astronomy00.1%
    8. Earth and Planetary Sciences00.0%
    1. Economics, Econometrics and Finance00.3%
    2. Social Sciences00.3%
    3. Decision Sciences00.1%
    4. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.40× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.11× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 13.58× its world share, 2 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 16.27× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.52× its world share, 0 worksChemistryComputer Science: 0.37× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.06× its world share, 0 worksEarth and Planetary …Engineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMedicine: 2.73× its world share, 9 worksMedicineDecision Sciences: 0.99× its world share, 0 worksDecision SciencesSocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 16.3×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics16.27×1 works
  2. Immunology and Microbiology13.58×2 works
  3. Biochemistry, Genetics and Molecular Biology3.11×3 works
  4. Medicine2.73×9 works
  5. Chemistry1.52×0 works
  6. Decision Sciences0.99×0 works
  7. Agricultural and Biological Sciences0.40×0 works
  8. Computer Science0.37×0 works
  9. Environmental Science0.20×0 works
  10. Social Sciences0.10×0 works
  11. Engineering0.07×0 works
  12. Earth and Planetary Sciences0.06×0 works

Who are the top researchers at Rigel (United States)?

Ranked on the quality score, Donald G. Payan, Chrystelle Lamagna and Susan M. Molineaux lead among researchers whose main affiliation is Rigel (United States).

  1. 1 Donald G. Payan United States · #455,146 worldwide 13k citations · 220 works
  2. 2 Chrystelle Lamagna United States · #619,914 worldwide 1.6k citations · 42 works
  3. 3 Susan M. Molineaux United States · #686,168 worldwide 5.3k citations · 28 works
  4. 4 Sacha J. Holland United States · #693,788 worldwide 3.7k citations · 57 works
  5. 5 Yonchu Jenkins United States · #799,056 worldwide 2.8k citations · 77 works
  6. 6 Betty C. B. Huang United States · #819,428 worldwide 5.6k citations · 47 works
  7. 7 Elliott B. Grossbard United States · #821,854 worldwide 3.3k citations · 40 works
  8. 8 Ann M. Lowe United States · #1,343,481 worldwide 1.8k citations · 15 works
  9. 9 Sylvia Braselmann United States · #1,390,350 worldwide 1.7k citations · 22 works
  10. 10 Sandra Tong United States · #1,393,355 worldwide 583 citations · 21 works
All ranked researchers at Rigel (United States)

What are the most cited papers from Rigel (United States)?

The most cited paper from Rigel (United States) is "Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia" (Jonathan W. Friedberg, Jeff Porter Sharman, John William Sweetenham et al., 2009), with 747 citations. Next come "MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α" (535) and "R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation" (520).

Most cited papers
#PaperReleasedCitations
1 Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia Jonathan W. Friedberg, Jeff Porter Sharman, John William Sweetenham et al. · Blood Open access 18 Nov 2009 747
2 MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α Baoxue Ge, Hermann Gram, Franco Di Padova et al. · Science 15 Feb 2002 535
3 R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation Sylvia Braselmann et al. · Journal of Pharmacology and Experimental Therapeutics 31 Aug 2006 520
4 c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention James G. Christensen, Jon Burrows, Ravi Salgia · Cancer Letters 12 Nov 2004 518
5 An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis Michael E. Weinblatt, Arthur Kavanaugh, Mark C. Genovese et al. · New England Journal of Medicine 29 Sep 2010 382
All 60 most cited papers, with filters and sorting

Which keywords describe research at Rigel (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Cancer Therapy, Rituximab, Immune Response, Mutation, Cytokines and Immune Responses.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation25▲ 8.2×28 topics
  2. Cancer12▲ 6.5×21 topics
  3. Epidemiology8▲ 1.61×18 topics
  4. Cancer Therapy8▲ 9.9×9 topics
  5. Rituximab6▲ 30×4 topics
  6. Immune Response6▲ 7.6×8 topics
  7. Mutation6▲ 30×3 topics
  8. Cytokines6▲ 17×3 topics
  9. Immune Responses6▲ 46×3 topics
  10. Allergic Disease5▲ 178×1 topic
  11. Mast Cells5▲ 178×1 topic
  12. Prognostic Factors5▲ 9.3×8 topics
  13. Thrombosis5▲ 18×5 topics
  14. Glycosylation5▲ 17×3 topics
  15. Tumor Microenvironment5▲ 11×5 topics
  16. Management5▲ 4.7×9 topics
  17. Tumor Suppression4▲ 29×3 topics
  18. Pattern Recognition Receptors4▲ 22×2 topics
  19. Fc Receptors4▲ 31×1 topic
  20. Therapeutic Antibodies4▲ 24×1 topic
  21. Therapeutic Targets4▲ 13×3 topics
  22. Cancer Immunotherapy4▲ 21×3 topics
  23. Chronic Lymphocytic Leukemia4▲ 59×1 topic
  24. Genomic Aberrations4▲ 59×1 topic
  25. Medicinal Chemistry4▲ 7.7×7 topics
  26. Toll-like Receptors4▲ 17×2 topics
  27. BCR-ABL4▲ 100×1 topic
  28. Imatinib4▲ 100×1 topic
  29. Cytokine-Mediated Link4▲ 39×1 topic
  30. Drug Discovery4▲ 6.8×7 topics
  31. Innate Antiviral Responses4▲ 39×1 topic
  32. IL-63▲ 80×1 topic
  33. STAT33▲ 80×1 topic
  34. Apoptosis3▲ 6.5×6 topics
  35. Hemostasis3▲ 16×2 topics
  36. Immune Thrombocytopenic Purpura3▲ 60×1 topic
  37. Platelets3▲ 37×1 topic
  38. Proteasome Inhibitors3▲ 34×2 topics
  39. Immune Regulation3▲ 17×3 topics
  40. Immunosuppressive Therapy3▲ 12×4 topics

Which research topics does Rigel (United States) publish most on?

By volume in 2022-now: Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Pharmacological Effects of Natural Compounds and Chronic Myeloid Leukemia Treatments.

Acute Myeloid Leukemia R…1Acute Myeloid Leukemia Research: 1 fractional worksMyeloproliferative Neopl…1Myeloproliferative Neoplasms: Diagnosis and Treatment: 1 fractional worksPharmacological Effects …1Pharmacological Effects of Natural Compounds: 1 fractional worksChronic Myeloid Leukemia…1Chronic Myeloid Leukemia Treatments: 1 fractional worksPlatelet Disorders and Treatments: 1 fractional worksPancreatic function and diabetes: 1 fractional worksCytokine Signaling Pathw…1Cytokine Signaling Pathways and Interactions: 1 fractional worksMetabolism, Diabetes, an…1Metabolism, Diabetes, and Cancer: 1 fractional worksChronic Lymphocytic Leuk…1Chronic Lymphocytic Leukemia Research: 1 fractional worksImmune Response and Infl…0Immune Response and Inflammation: 0 fractional works
HematologyGeneticsPharmacologySurgery3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 1 works
  2. 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  3. 3 Pharmacological Effects of Natural Compounds Pharmacology 1 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 1 works
  5. 5 Platelet Disorders and Treatments Hematology 1 works
  6. 6 Pancreatic function and diabetes Surgery 1 works
  7. 7 Cytokine Signaling Pathways and Interactions Oncology 1 works
  8. 8 Metabolism, Diabetes, and Cancer Molecular Biology 1 works
  9. 9 Chronic Lymphocytic Leukemia Research Genetics 1 works
  10. 10 Immune Response and Inflammation Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 40% of research is openly available.

with international co-authors21.3%domestic only78.7%

World: 18% is written across borders.

How has Rigel (United States)'s research output changed?

Output in 2022-2025 was 5% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Rigel (United States) as a percentage of every work published that year, 0.000056% in 2024.

still counting0.00020%0.00040%0.00060%Rigel (United States)0.000034% in 20251990200020102020

Fractional works of Rigel (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in San Francisco

All research institutions in San Francisco

Share Rigel (United States)'s ranking

Rigel (United States) on Science Explorer

A card with Rigel (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Rigel (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.